Mount Vernon Cancer Centre, Rickmansworth Road, Northwood HA6 2RN
The public consultation about the proposals for Mount Vernon Cancer Centre has closed. Please scroll to the bottom of this page for further information.
Patient and visitor travel survey: NHS England want to hear about your experience of travelling to the cancer centre or the Paul Strickland Scanner Centre and also to hear from people who did not have treatment because it was too far or too difficult to get to. Please share your views on the travel and access survey page before 17 May 2026.
Mount Vernon Cancer Centre is a well renowned, specialist cancer centre in Northwood, Middlesex.
As a centre of excellence we pride ourselves on both our technical treatments and our patient care. Our staff is highly trained in non-surgical oncology.
The consultant team are highly respected and each specialises in one or two particular cancers. There is also a team of doctors who support the consultants’ clinical work both in the outpatient clinics and on the wards. Nurses deliver chemotherapy treatments and radiographers deliver radiotherapy treatments all supported by teams of physicists, administration staff and engineers.
There are over 500 members of staff and we are united in our goal to provide high quality and timely treatment to our patients.
We treat from a large catchment population of almost 2 million people and some patients are referred to us from across the country into areas where we have specialist knowledge and expertise. Over 5,000 new patients are registered with us each year.
Mount Vernon Cancer Centre prides itself on being at the forefront of the latest technology available for treatment and many patients being offered clinical trials for both chemotherapy and radiotherapy treatments. The centre has the latest pumps for the delivery of chemotherapy and in radiotherapy the most up to date linear accelerators can deliver the latest treatment techniques.
We have produced a series of information films to help support and reassure patients before they start cancer treatment. The films include information about what to expect during an appointment, the different devices that might be used as well as guidance on travel and parking at the centre. The films are available to watch on our YouTube channel.
Our facilities include:
- A chemotherapy/immunotherapy suite, which treats around 300 patients a week using 21, providing systemic anti-cancer therapy using established and cutting edge drug treatments for all cancer types
- Inpatient ward, which has 26 beds
- A comprehensive radiotherapy service from the point of clinical referral to the first follow-up appointment
- Seven linear accelerators providing radiotherapy treatments, including CyberKnife and TrueBeam
- Nuclear Medicine Imaging and Outpatient Therapy service
- Iodine suite treating 120 patients per year
Our team of volunteers is available to help patients way find their way around our rather complex site. If you need help, just look out for the people wearing a yellow sash or a yellow lanyard and a yellow badge.
Also part of the cancer centre are three facilities that support our patients:
The Paul Strickland Scanner Centre
Provides comprehensive scanning services to the NHS and private health sectors for the diagnosis, treatment monitoring and research of cancer and other serious diseases, using leading edge PET/CT, MRI and CT scanners.
The Lynda Jackson Centre
Situated next to the Cancer Treatment Suite (near the Gate 3 entrance), the Lynda Jackson Centre offers support and information services for patients, relatives and carers before, during and after cancer treatment. The Centre is open Monday to Friday (9.30am – 4.30pm) and offers a drop-in service so patients and their families can ask for help, support, information and advice.
The Centre also offers a programme of health and wellbeing services which includes counselling, group relaxation classes, complementary therapies and workshops to support patients experiencing side effects of having treatment for cancer such as hair loss. Some of these services are run in person and some online or by telephone.
To make a booking or find out more please call 020 3826 2555 (Monday to Friday, 9:30am – 4:30pm) or email enh-tr@[email protected]. The Lynda Jackson Centre website is unavailable at the moment due to essential maintenance. Please call or email the team for help and support.
Coronavirus guidance
For the latest Covid-19 information for patients and visitors, please click here.
Building works
Mount Vernon Cancer Centre has been awarded £7.5 million to make building improvements. The works are ongoing and scheduled for completion in early 2026. You can find out more by visiting the ‘Building works at the Mount Vernon Cancer Centre’ section of our website.
Mount Vernon Cancer public consultation
The public consultation on proposals to move Mount Vernon Cancer Centre to a new facility next to the new Watford General Hospital started on 19 January 2026 and closed on 29 March 2026.
Patients and visitors travel survey
Travel and access was one of the top issues in the public consultation so NHS England is running a more detailed project on this. Please share your experience of travelling to the cancer centre and also please share your views if you chose not to have treatment at Mount Vernon because it was too far or too difficult to get to. Please respond via the travel and access survey page
Background to the public consultation
Please click here to read the announcement about the consultation.
In 2019 NHS England launched a strategic review about the future sustainability of services. An Independent Clinical Review found that there needed to be immediate and longer-term changes including moving specialist cancer services to a new centre on a main hospital site and recommendations to maintain the current service, including a building improvement programme.
A series of options for Mount Vernon Cancer Centre were developed. You can find detailed information about this on the Mount Vernon Cancer Services Review website.
We understand that news of changes can be worrying for patients and would like to offer reassurance that during the review and public consultation there will be no immediate or short-term changes to where patients go for their treatment.
